REG - Eagle Capital Mgt. Willis Towers Watson - Form 8.3 - [Willis Towers Watson Plc]

Willis Towers WatsonAnnouncement

09/06/2021 15:25

RNS Number : 3775B
  
Eagle Capital Management, LLC
  
09 June 2021
  
 

 
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


Eagle Capital Management, LLC
 




Company dealt in


Willis Towers Watson Plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


Common Stock (IE00BDB6Q211)




Date of dealing


8 June 2021




 
2.         INTERESTS AND SHORT POSITIONS
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) 




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


2,159,004 (1.67%)


 




(2) Derivatives (other than options)


N/A


 




(3) Options and agreements to purchase/sell


N/A


 




Total


2,159,004 (1.67%)


 



 
 
 
 
 
 
 



 
 
Note: the differences between the total interests noted above and those in the Form 8.3 dated June 8, 2021 are as a result of the recognition of certain passive transfers in or out of WLTW shares to accounts managed by Eagle Capital Management, LLC as a result of client onboarding or redemptions.
 
(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) 




Class of relevant security:


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


N/A


 




 
(2) Derivatives (other than options)


N/A


 




 
(3) Options and agreements to purchase/sell


N/A


 




Total


N/A


 



 
 
 
 
 
 
 




 

 
3.       DEALINGS (Note 4) 
 
(a)      Purchases and sales
 




Purchase/sale


Number of relevant securities


Price per unit (Note 5)




BUY


34


USD 254.55




 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(Note 5)




N/A


 


 


 




 
 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5)




N/A


 


 


 


 


 


 




 
 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




N/A


 


 




 
 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




N/A


 


 





 

 
4.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and 
any other person relating to the voting rights of any relevant securities under any option referred to 
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 
which any derivative referred to on this form is referenced. If none, this should be stated.
 
                                               
                                               NONE
 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            NO
 




Date of disclosure


9 June 2021




Contact name


Mark Robertson




Telephone number


+1 212-293-4008




If a connected EFM, name of offeree/offeror with which connected


N/A




If a connected EFM, state nature of connection (Note 10)


N/A




 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISEZKLFBFQLLBBL